Moderna stock after-hours at EUR 176.87: plus 1.89 percent versus Lang & Schwarz prior close
Published on 09/29/2026 at 21:09 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Moderna stock was at EUR 176.87 in after-hours trading at 9:06 p.m. CEST on September 29, 2026, according to Lang & Schwarz. The price was up plus 1.89 percent versus the Lang & Schwarz prior close of EUR 173.59.
After-hours trading in Germany
The Lang & Schwarz quote showed a bid of EUR 176.60 and an ask of EUR 177.14. The indication is separate from Moderna’s company announcements and does not establish a cause for the session’s price movement.
ESMO presentation and investor webcast
Moderna, Inc. said in a September 21 press release that Phase 3 data for intismeran autogene in the adjuvant treatment of patients with resected stage IIB-IV melanoma had been selected for presentation at a Presidential Symposium during the 2026 ESMO Congress. The company also announced an investor webcast for Saturday, October 24, at 7:00 p.m. CEST. The announcement was published by Moderna, Inc.
Moderna’s oncology research
In a September 24 company-authored article, Moderna Chief Development Officer David Berman described the company’s individualized neoantigen therapy with Merck as an example of mRNA-based oncology research. He also said Moderna is investigating an mRNA approach in Lynch syndrome, an early-stage research effort aimed at training the immune system to detect cells carrying certain abnormal mutations. The article appeared on Moderna’s website.
